Learn More
Medchemexpress LLC 4-Hydroxymethylpyrazole | 25222-43-9 | 99.7% | 98.11 | 5 G

Supplier: Medchemexpress LLC HY339145G
4-Hydroxymethylpyrazole is the primary metabolite of Fomepizole, produced through hepatic oxidative metabolism. It has a plasma concentration positively correlated with the administered dosage of Fomepizole and a relatively short half-life. It inhibits alcohol dehydrogenase (ADH) in humans and monkeys, but its inhibition constant is significantly higher than Fomepizole's, rendering its in vivo impact negligible.
- Primary metabolite of Fomepizole
- Produced through hepatic oxidative metabolism
- Plasma concentration positively correlated with administered dosage
- Relatively short half-life
- Inhibits alcohol dehydrogenase (ADH) in humans and monkeys
- In vivo impact negligible
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.